<code id='2E28C2AFFC'></code><style id='2E28C2AFFC'></style>
    • <acronym id='2E28C2AFFC'></acronym>
      <center id='2E28C2AFFC'><center id='2E28C2AFFC'><tfoot id='2E28C2AFFC'></tfoot></center><abbr id='2E28C2AFFC'><dir id='2E28C2AFFC'><tfoot id='2E28C2AFFC'></tfoot><noframes id='2E28C2AFFC'>

    • <optgroup id='2E28C2AFFC'><strike id='2E28C2AFFC'><sup id='2E28C2AFFC'></sup></strike><code id='2E28C2AFFC'></code></optgroup>
        1. <b id='2E28C2AFFC'><label id='2E28C2AFFC'><select id='2E28C2AFFC'><dt id='2E28C2AFFC'><span id='2E28C2AFFC'></span></dt></select></label></b><u id='2E28C2AFFC'></u>
          <i id='2E28C2AFFC'><strike id='2E28C2AFFC'><tt id='2E28C2AFFC'><pre id='2E28C2AFFC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:52
          Adobe

          Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

          The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

          advertisement

          Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk
          Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          FTC sues over Novant Health acquisition of two N.C. hospitals

          AlexBrandon/APThefederalgovernmentissuingtoblockaproposedhospitaldealinNorthCarolina,allegingitwould